NCT05876403Completed
Respiratory Proprioceptive Neuromuscular Facilitation Technique in Chronic Pulmonary Obstructive Disease Patients.
Effects of Respiratory Proprioceptive Neuromuscular Facilitation (PNF) Technique on Pulmonary Function of Chronic Pulmonary Obstructive Disease (COPD) Patients.
Source: ClinicalTrials.gov · Last updated 30 Jan 2024
Brief summary (registry, in English)
The purpose of this study is to evaluate the impact of PNF technique combined with aerobic exercises among COPD patients in a clinical setting. Previous literature has evaluated this technique in ventilated patients but in clinical setting specifically in Pakistan, this invention therapy has not been implied in COPD patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 56 (actual)
- First submitted
- 17 May 2023
- Start date
- 1 Sept 2023
- Primary completion date
- 15 Nov 2023
- Lead sponsor
- Riphah International University
- Diseases
- COPD
- NCT number
- NCT05876403
What you commit to
- Study type: Interventional
- Participants enrolled: 56
- From 1 Sept 2023 to the primary completion date, 15 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with recent chest wall trauma, surgery or deformity.
Other illness
- Serious conditions with require supplementary oxygen or ventilator/support devices.
- Patient with neurological, psychological, musculoskeletal, or cardiac medical history.
- Pulmonary disease with physical impairment.
Other
- COPD exacerbation within last 4weeks
- Inability to follow the pulmonary rehabilitation program.
Who the study is looking for
- Both male \& female participants.
- Diagnosed COPD patients
- Age 35-60years
- Ratio of forced expiratory volume in first second \& forced vital capacity(FEV1/FVC \<0.7,30%\<FEV1\<80%
- Stable clinical condition.
Age in the registry: 35 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pakistan Railway General Hospital Coordinator of this site? Confirm its status | Islamabad | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.